PSR Ovarian Cancer With a BRCA Mutation
1 clinical trials · Condition
◉ Watch PSR Ovarian Cancer With a BRCA Mutation
| Record | Firm | Date |
|---|---|---|
| Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan (NCT03063710) | AstraZeneca |
Track PSR Ovarian Cancer With a BRCA Mutation automatically
Every clearance here is in the API, with alerts when new ones post.